Peptide Directory
The peptide resource
built for stack tracking.
Research compounds, compare outcome areas, and understand side effect patterns before you log a stack. Then move directly into structured tracking when you're ready.
GLP-1
Semaglutide
GLP-1 receptor agonist
Semaglutide is a GLP-1 receptor agonist used in prescription care for diabetes and chronic weight management. PeptideStack treats it as a tracking hub for appetite, GI symptoms, nutrition, body-composition change, and visible side effects.
Weight-management research
Weeks to months
Glucose-control context
Weeks
Side-effect tracking
First weeks and titration windows
GLP-1
Tirzepatide
Dual GIP/GLP-1 agonist
Tirzepatide is a dual GIP/GLP-1 agonist used in prescription metabolic care. For PeptideStack users, the practical need is tracking appetite, GI symptoms, nutrition, sleep, body-composition change, and support routines around a clinician-directed plan.
Weight-management research
Weeks to months
Metabolic context
Weeks
Support-stack tracking
Ongoing
GLP-1
Retatrutide
Investigational triple agonist
Retatrutide is an investigational incretin compound that has become a high-curiosity comparison point for GLP-1 users. It belongs in PeptideStack as a research and tracking context page, not a consumer protocol page.
Obesity trial context
Months in trials
Comparison research
Ongoing
Symptom-tracking prep
Before and during any supervised plan
GLP-1
Liraglutide
GLP-1 receptor agonist
Liraglutide is an earlier GLP-1 medication still relevant for users comparing daily versus weekly GLP-1 tracking patterns. It is useful as a schedule, symptom, appetite, and nutrition-tracking profile.
Weight-management research
Weeks to months
Glucose-control context
Weeks
Daily schedule tracking
Ongoing
Healing
BPC-157
Investigational recovery peptide
BPC-157 is one of the highest-interest recovery peptides in injury, gut, and post-procedure conversations. PeptideStack frames it around evidence limits, recovery tracking, symptom notes, and clinician caution.
Tendon and soft-tissue models
Research models vary
Gut and inflammatory models
Research models vary
Recovery tracking
Weeks
Healing
TB-500
Thymosin beta-4 related peptide
TB-500 is commonly discussed as a recovery peptide related to thymosin beta-4 biology. PeptideStack presents it as a cautious recovery-tracking profile with evidence-context links, not as a shortcut claim.
Wound and tissue-repair models
Research models vary
Connective-tissue recovery tracking
Weeks
BPC comparison context
Ongoing
Beauty
GHK-Cu
Copper tripeptide
GHK-Cu is a clear visible-change tracking profile for PeptideStack because users research skin quality, hair, wound appearance, and visible changes during weight loss. PeptideStack keeps route and evidence differences clear.
Skin-quality context
Weeks to months
Hair and scalp context
Months
Visible-change tracking
Ongoing
Healing
KPV
Anti-inflammatory peptide fragment
KPV is researched as an anti-inflammatory peptide fragment, especially around gut and skin inflammatory models. PeptideStack frames it as mechanism context plus symptom tracking.
Gut inflammation models
Research models vary
Skin irritation context
Weeks
Symptom tracking
Ongoing
Healing
Thymosin alpha-1
Immune-modulating peptide
Thymosin alpha-1 is researched for immune modulation and infectious-disease or oncology adjunct contexts. In PeptideStack, it appears as a serious immune-context profile with medical-supervision boundaries.
Immune modulation research
Condition-specific
Adjunct clinical contexts
Condition-specific
Safety-context tracking
Ongoing
Performance
AOD-9604
Investigational metabolic peptide
AOD-9604 is researched by users interested in body composition and metabolic support. The launch-safe posture is cautious comparison and outcome tracking, especially because evidence is much thinner than GLP-1 medications.
Body-composition interest
Weeks to months
GLP-1 comparison context
Ongoing
Metabolic-note tracking
Ongoing
Performance
CJC-1295
Growth hormone secretagogue analog
CJC-1295 is researched around growth-hormone signaling, recovery, sleep, and body composition. PeptideStack keeps it evidence-limited and uses it to track recovery variables rather than imply performance outcomes.
GH-axis research
Hours to weeks in studies
Sleep and recovery tracking
Weeks
Ipamorelin comparison context
Ongoing
Performance
Ipamorelin
Growth hormone secretagogue
Ipamorelin is researched for GH-axis signaling and often compared with CJC-1295 in recovery stacks. PeptideStack treats it as a sleep, recovery, appetite, and safety-context tracker.
GH-axis pharmacology
Acute to short-term studies
Recovery tracking
Weeks
Stack comparison
Ongoing
Performance
Tesamorelin
Growth hormone-releasing factor analog
Tesamorelin is different from many performance peptides because it has an approved prescription context for reducing excess abdominal fat in adults with HIV-associated lipodystrophy. PeptideStack keeps that indication clear.
HIV-associated lipodystrophy context
Months in trials
Body-composition tracking
Months
GH-axis safety context
Ongoing
Performance
Sermorelin
Growth hormone-releasing hormone analog
Sermorelin is researched and marketed around GH-axis support, sleep, recovery, and aging claims. PeptideStack treats it as a conservative endocrine-context tracker.
GH-axis context
Condition-specific
Sleep/recovery tracking
Weeks
Aging-claim audit
Ongoing
Performance
Bremelanotide / PT-141
Melanocortin receptor agonist
Bremelanotide, also known as PT-141, is a melanocortin receptor agonist with an approved prescription context for acquired, generalized hypoactive sexual desire disorder in premenopausal women. PeptideStack separates that label from casual performance claims.
Approved-label context
Event-specific in labeling
Symptom and side-effect tracking
Hours to days
Boundary setting
Always visible